Respiratory Infections News

Novavax said Monday that it has asked the FDA to authorize a booster shot of its COVID-19 vaccine.

The FDA has approved the oral influenza medication Xofluza for children aged 5 to 11 years who have been symptomatic for no more than 48 hours, Genentech announced.

The FDA recommended that people take multiple at-home COVID-19 antigen tests to confirm a negative result, whether they have symptoms or not.

Fatigue and headache were the most common symptoms reported by people an average of 4 months after COVID-19 infection, according to research in Brain, Behavior, & Immunity.

Patients with COVID-19 had a higher risk for hospital-onset antibiotic-resistant infections compared with patients with influenza-like illness before the pandemic, according to a study published in Clinical Infectious Diseases.

Long COVID increases children’s risk for several serious conditions, although the conditions remain rare, according to findings reported in MMWR.

Exposure to young children was associated with less severe COVID-19 illness among adults, according to a study published in the Proceedings of the National Academy of Sciences of the United States of America.

Undergoing preventive dental treatment within 12 months or periodontal treatment within 6 months of hospitalization was associated with a reduced risk for nonventilator hospital-acquired pneumonia, researchers found.

President Joe Biden tested positive for SARS-CoV-2 again on Monday, the White House announced — the third day in a row he tested positive after testing negative for 3 days last week.

In a new study, researchers reported systematic racial differences in ICU admission patterns among patients with acute respiratory failure and sepsis who are Asian, Pacific Islander and Hispanic.